Traders Union
All News
Biotechnology, Research, and Healthcare by Nuvalent

Advertiser Disclosure

Biotechnology, Research, and Healthcare by Nuvalent

Nuvalent stock slides 1.33 percent as #ASCO26 event wraps, Nuvalent reports clinical updates

Dan Blystone
08.06.2026

Nuvalent stock slides 1.33 percent as #ASCO26 event wraps, Nuvalent reports clinical updates

Nuvalent wrapped up its participation at the 2026 ASCO Annual Meeting with presentations on its clinical updates. The company presented updates from its ALK+ NSCLC and ROS1+ programs.Nuvalent ...

Nuvalent stock falls to $90.95 amid oversold conditions and ongoing bearish momentum

Dan Blystone
07.06.2026

Nuvalent stock falls to $90.95 amid oversold conditions and ongoing bearish momentum

Nuvalent marked National Cancer Survivors Day by acknowledging the strength and resilience of cancer survivors. The company focused on those living with ALK+ and ROS1+ lung cancer.Nuvalent ...

Nuvalent celebrates ALK Awareness Month as Nuvalent stock trades up to $92.08 amid weak momentum

Parshwa Turakhiya
03.06.2026

Nuvalent celebrates ALK Awareness Month as Nuvalent stock trades up to $92.08 amid weak momentum

Nuvalent announced its support for ALK Awareness Month and the ALK lung cancer community.Nuvalent referenced the #FuelTheCure initiative, recognizing patients, researchers, and advocates for their ...

Upcoming AACR 2026 event announcement sees Nuvalent stock down 1.43%

Hanna Syniavska
29.03.2026

Upcoming AACR 2026 event announcement sees Nuvalent stock down 1.43%

Nuvalent will present new clinical and preclinical data for its ROS1+ NSCLC program at the AACR 2026 Annual Meeting in San Diego.The company announced its participation in the event via Twitter. ...

Nuvalent to unveil new ROS1+ NSCLC clinical and preclinical data at AACR 2026

Eugene Komchuk
18.03.2026

Nuvalent to unveil new ROS1+ NSCLC clinical and preclinical data at AACR 2026

Nuvalent announced plans to present new clinical and preclinical data for its ROS1-positive non-small cell lung cancer (NSCLC) program at the AACR 2026 Annual Meeting in San Diego. The upcoming ...

Nuvalent honors women pioneers on Women in Science Day

Ivan Andriyenko
11.02.2026

Nuvalent honors women pioneers on Women in Science Day

Nuvalent commemorates the International Day of Women and Girls in Science by celebrating the contributions of female pioneers in science. The company acknowledges the courage and achievements of ...

Nuvalent unveils patient outcomes data at key cancer conference

Viktoras Karapetjanc
05.11.2025

Nuvalent unveils patient outcomes data at key cancer conference

Nuvalent is set to present significant data at the 2025 IASLC ASCO North America Lung Cancer Conference. This presentation will mark the first public disclosure of patient-reported outcomes from ...

© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.
Disclaimer:

Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Disclosure of advertisers and revenues:

All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.